• Return to Headlines

A Healthcare Bill Signing Update: Nektar Therapeutics 19.8% Below its March 23rd 'Healthcare Bill Signing' Low of $15.04 (NKTR)

Written on Thu, 07/22/2010 - 6:21am
By Chip Brian

Nektar Therapeuticsis currently trading 19.8% below its March 23rd low of $15.04. Investors are looking to see if the shares can regain the March 23rd 'Healthcare Bill Signing' level, which may act as long-term overhead resistance.
In the past 52-weeks, shares of Nektar Therapeutics (NASDAQ:NKTR) have traded between a low of $6.46 and a high of $15.84 and are now at $12.06, which is 86.7% above that low price.
SmarTrend is bearish on shares of Nektar Therapeutics and our subscribers were alerted to Sell on April 26, 2010 at $13.76. The stock has fallen 12.3% since the alert was issued.

Keywords: nektar therapeutics healthcare bill

Ticker(s): NKTR

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.